• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PLSE

PLSE

Pulse Biosciences, Inc.

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD24.99

+0.71 (+2.92%)

Rating:C

Company Profile

CEO

Paul Arthur LaViolette

IPO Date

2016-05-18

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$24.27

Prev. Close

$24.28

Day Low

$23.67

Day High

$25.18

52W Low

$12.56

52W High

$27.98

Market Cap

$1.73B

Volume

0.26M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

21.9%

Avg Negative

12.6%

Avg Neutral

65.4%

News Feed

Why Pulse Biosciences Stock Moved Higher Thursday

The Motley Fool·7/1/2021·↑ positive

Pulse Biosciences Stock Is Trading Higher After Company's Chairman Agrees To Buy Shares Worth $50M

Benzinga·7/1/2021·↑ positive

PLSE Stock Price Increases Over 48%: Why It Happened

Pulse2·7/1/2021·↑ positive

Pulse Biosciences Announces First CellFX® Procedure Performed in Canada

Business Wire·6/30/2021·↑ positive

Moving Average Crossover Alert: Pulse Biosciences (PLSE)

Zacks Investment Research·6/11/2021·↓ negative

Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference

Business Wire·5/13/2021·↑ positive

Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/10/2021·↓ negative

Pulse Biosciences to Participate in Upcoming Investor Conferences

Business Wire·3/5/2021·↑ positive

Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/22/2021·↓ negative

Pulse Biosciences Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for February 22, 2021

Business Wire·2/12/2021·↑ positive